Showing results (151-160 of 180) with videos related to
Sort By:
Pageof 18
Breast Cancer Research and Treatment|September 27, 2005
Systemic effects of surgery: quantitative analysis of circulating basic fibroblast growth factor (bFGF), Vascular endothelial growth factor (VEGF) and transforming growth factor beta (TGF-beta) in patients with breast cancer who underwent limited or extended surgeryG Curigliano, J Y Petit, F Bertolini, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 12, 2002
Very young women (<35 years) with operable breast cancer: features of disease at presentationM Colleoni, N Rotmensz, C Robertson, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 10, 2008
The value of radiotherapy on metastatic internal mammary nodes in breast cancer. Results on a large seriesU Veronesi, P Arnone, P Veronesi, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1997
Efficacy, toxicity, and applicability of high-dose sequential chemotherapy as adjuvant treatment in operable breast cancer with 10 or more involved axillary nodes: five-year resultsA M Gianni, S Siena, M Bregni, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 25, 2007
Prognostic role of the extent of peritumoral vascular invasion in operable breast cancerM Colleoni, N Rotmensz, P Maisonneuve, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 8, 2007
Expression of ER, PgR, HER1, HER2, and response: a study of preoperative chemotherapyM Colleoni, G Viale, D Zahrieh, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 25, 2010
Prognosis and adjuvant treatment effects in selected breast cancer subtypes of very young women (<35 years) with operable breast cancerG Cancello, P Maisonneuve, N Rotmensz, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 21, 2014
Changes in PgR and Ki-67 in residual tumour and outcome of breast cancer patients treated with neoadjuvant chemotherapyE Montagna, V Bagnardi, G Viale, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 2, 2012
Progesterone receptor loss identifies Luminal B breast cancer subgroups at higher risk of relapseG Cancello, P Maisonneuve, N Rotmensz, et al.European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|January 10, 2016
Sentinel node biopsy after neoadjuvant treatment in breast cancer: Five-year follow-up of patients with clinically node-negative or node-positive disease before treatmentV Galimberti, S K Ribeiro Fontana, P Maisonneuve, et al.Pageof 18